117 related articles for article (PubMed ID: 33397842)
21. Diabetes and COVID-19: What we learned from the two ongoing pandemics.
Torquato MTDCG; Santis GC; Zanetti ML
Rev Lat Am Enfermagem; 2021 Oct; 29():e3285. PubMed ID: 34730758
[No Abstract] [Full Text] [Related]
22. Diabetes, Obesity, and Risk Prediction of Severe COVID-19.
Muniyappa R; Wilkins KJ
J Clin Endocrinol Metab; 2020 Oct; 105(10):. PubMed ID: 32663259
[No Abstract] [Full Text] [Related]
23. Characteristics and outcomes of diabetic patients infected by the SARS-CoV-2.
Elamari S; Motaib I; Zbiri S; Elaidaoui K; Chadli A; Elkettani C
Pan Afr Med J; 2020; 37():32. PubMed ID: 33209159
[TBL] [Abstract][Full Text] [Related]
24. Recommendations for the care of patients with diabetes mellitus with risk factors or established cardiovascular disease and SARS-CoV-2mellitus con factores de riesgo o enfermedad cardiovascular establecida y SARS-CoV-2.
Alcocer-Gamba MA; Gutiérrez-Fajardo P; Sosa-Caballero A; Cabrera-Rayo A; Faradji-Hazan RN; Padilla-Padilla FG; Garnica-Cuellar JC; Hernández-Arispe LM; Reyes-Cianeros FA; León-Suárez A; de-Jesús-Rivera J; Mancillas-Adame L; Gaxiola-Macias M; Márquez-Rodríguez E; Miranda-Malpica E; Sanchez-Pedraza V; Lara-Martínez DS; Segovia-Palomo A; Nava-Hernández A; Rivera-Reyes R
Arch Cardiol Mex; 2020; 90(Supl):77-83. PubMed ID: 32523151
[TBL] [Abstract][Full Text] [Related]
25. Time for a Change: Personal Experiences With COVID-19 and Diabetes.
Best F
J Diabetes Sci Technol; 2020 Jul; 14(4):716-717. PubMed ID: 32443943
[No Abstract] [Full Text] [Related]
26. Diabetes and COVID-19: Moving From News to Knowledge and a Glucose Hypothesis.
Riddle MC
Diabetes Care; 2020 Oct; 43(10):2336-2338. PubMed ID: 32753458
[No Abstract] [Full Text] [Related]
27. SARS-CoV-2 perturbs the renin-angiotensin system and energy metabolism.
Mori J; Oudit GY; Lopaschuk GD
Am J Physiol Endocrinol Metab; 2020 Jul; 319(1):E43-E47. PubMed ID: 32469255
[TBL] [Abstract][Full Text] [Related]
28. Increased Hepatic ACE2 Expression in NAFL and Diabetes-A Risk for COVID-19 Patients?
Soldo J; Heni M; Königsrainer A; Häring HU; Birkenfeld AL; Peter A
Diabetes Care; 2020 Oct; 43(10):e134-e136. PubMed ID: 32753456
[No Abstract] [Full Text] [Related]
29. Low- and middle-income countries face up to COVID-19.
Shuchman M
Nat Med; 2020 Jul; 26(7):986-988. PubMed ID: 32439872
[No Abstract] [Full Text] [Related]
30. Early Observation and Mitigation of Challenges in Diabetes Management of COVID-19 Patients in Critical Care Units.
Hamdy O; Gabbay RA
Diabetes Care; 2020 Aug; 43(8):e81-e82. PubMed ID: 32444458
[No Abstract] [Full Text] [Related]
31. The association of diabetes with COVID-19 disease severity: evidence from adjusted effect estimates.
Liang X; Xu J; Xiao W; Shi L; Yang H
Hormones (Athens); 2021 Jun; 20(2):409-414. PubMed ID: 33236191
[No Abstract] [Full Text] [Related]
32. [COVID-19 and Diabetes Mellitus: The Impact of Two Pandemics].
Oliveira P; Louro J; Gil P; Andrade L
Acta Med Port; 2022 Dec; 35(12):925-926. PubMed ID: 36469954
[No Abstract] [Full Text] [Related]
33. Letter to the editor in response to the article "COVID-19 and diabetes: Can DPP4 inhibition play a role?".
Kokic Males V
Diabetes Res Clin Pract; 2020 May; 163():108163. PubMed ID: 32333972
[No Abstract] [Full Text] [Related]
34. [Not Available].
Fritschka E
MMW Fortschr Med; 2020 Oct; 162(18):31. PubMed ID: 33074500
[No Abstract] [Full Text] [Related]
35. Comment on Cai et al. Obesity and COVID-19 Severity in a Designated Hospital in Shenzhen, China. Diabetes Care 2020;43:1392-1398.
He Z; Li J
Diabetes Care; 2020 Oct; 43(10):e160-e161. PubMed ID: 32958624
[No Abstract] [Full Text] [Related]
36. Antihypertensive drugs and risk of COVID-19?
Tignanelli CJ; Ingraham NE; Sparks MA; Reilkoff R; Bezdicek T; Benson B; Schacker T; Chipman JG; Puskarich MA
Lancet Respir Med; 2020 May; 8(5):e30-e31. PubMed ID: 32222166
[No Abstract] [Full Text] [Related]
37. Increase in Diabetes Mortality Associated With COVID-19 Pandemic in the U.S.
Ran J; Zhao S; Han L; Ge Y; Chong MKC; Cao W; Sun S
Diabetes Care; 2021 Jul; 44(7):e146-e147. PubMed ID: 34135014
[No Abstract] [Full Text] [Related]
38. High Mortality Unaffected by Age, Gender and Steroid Use is the Hallmark of COVID-19 in Diabetes: Observations from a Retrospective Analysis during Peak of 2020 Pandemic in India.
Aggarwal R; Agrawal A; Gurtoo A; Suman V; Meena S; Prakash A
J Assoc Physicians India; 2021 May; 69(5):25-29. PubMed ID: 34189882
[No Abstract] [Full Text] [Related]
39. Impact of COVID-19 Pandemic on Pediatric Diabetes Mellitus.
Shin CH
J Korean Med Sci; 2022 Jun; 37(22):e186. PubMed ID: 35668690
[No Abstract] [Full Text] [Related]
40. Letter to the Editor regarding 'COVID-19 and diabetes: What does the clinician need to know?'.
Abbasi-Oshaghi E; Mirzaei F; Khodadadi I
Prim Care Diabetes; 2021 Feb; 15(1):30. PubMed ID: 33162350
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
